VEILLETTE, H. In Brief: Laboratory and clinical monitoring requirements for JAK inhibitors. Canadian Dermatology Today, Toronto, Canada, v. 4, n. 1, p. 20–22, 2023. Disponível em: https://canadiandermatologytoday.com/article/view/4-1-veillette. Acesso em: 23 nov. 2024.